Ventral Windowed Total Contact Casts Safely Offload Diabetic Feet and Allow Access to the Foot
- PMID: 33095036
- PMCID: PMC8875042
- DOI: 10.1177/1932296820964069
Ventral Windowed Total Contact Casts Safely Offload Diabetic Feet and Allow Access to the Foot
Abstract
Background: Irremovable total contact casts (TCCs) are the gold standard to offload diabetic foot ulcers (DFUs) and to immobilize feet with active Charcot neuro-osteoarthropathy (CN). They do not allow checks of the foot and are contraindicated in people with peripheral arterial disease (PAD). Frequently, removable TCCs and other removable devices are used because they allow wound care, modifications of the inner surface of the cast, and checks of the foot. The authors propose TCCs with ventral windows (VW-TCCs) whenever patients with high-risk conditions show poor adherence to wearing a removable cast all the time and access to the foot is necessary.
Methods: This retrospective study compares treatments with bivalved, removable TCCs applied prior to the introduction of the novel design (from 1 January 2016 to 1 July 2017, "c") to treatments in the following period (t) with both bivalved removable TCCs and VW-TCCs in use.
Results: Forty-five treatments after introduction (17 with the VW-TCC) showed a 52.8% lower median time to reach remission of the DFS than 41 controls (128/267 days, log-rank test P = .013). Reasons given for not using the novel design were: sufficient offloading with a removable TCC (16), patient preference (six), anatomical conditions (two), casts applied as a service for other facilities (three), and calf ulcers (one). Adverse effects from both designs were uncommon and not severe.
Conclusions: VW-TCCs combine advantages of both removable and irremovable TCCs. Complications do not limit the use, even in patients with PAD.
Keywords: Charcot foot; diabetic foot; diabetic foot ulcer; total contact cast; ventral window.
Conflict of interest statement
Figures
References
-
- Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137-149. - PubMed
-
- IDF. IDF diabetes atlas. 8th edition 2017. http://www.diabetesatlas.org. Accessed February 18, 2018.
-
- LeMaster JW, Reiber GE, Rayman A. Epidemiology and economic impact of foot ulcers. In: Boulton AJ, Cavenagh PR, Rayman A. (eds). The Foot in Diabetes. 4th ed. Chichester, West Sussex: John Wiley & Sons, Ltd; 2006.
-
- Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg. 1998;176(suppl 2A):5S-10S. - PubMed
-
- NHS. National diabetes foot care audit - 2014-2016. https://www.digital.nhs.uk/catalogue/PUB23525. Accessed March 23, 2018.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
